H.R. 10359

Priority for Pediatric Cures Act

Latest
Raw Text PDF XML

I

119th CONGRESS

2d Session

H. R. 10359

IN THE HOUSE OF REPRESENTATIVES

September 14, 2026

Mr. Bilirakis (for himself, Ms. Barragán, Mrs. Cammack, Mr. Auchincloss, Mr. Kean, and Mr. Mullin) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.

1.

Short title

This Act may be cited as the Priority for Pediatric Cures Act.

2.

Permanent extension of authority to award priority review vouchers for rare pediatric disease products

Section 529(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ff(b)) is amended by striking paragraph (5).